Increasing Ancestral Diversity in Systemic Lupus Erythematosus Clinical Studies

Jessica N Williams1, Maria Dall'Era2, S Sam Lim3

  • 1Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Summary

Non-White individuals with systemic lupus erythematosus (SLE) are underrepresented in clinical trials. Addressing societal and institutional barriers is crucial for increasing ancestral diversity in SLE research and optimizing treatments for all patients.